Robinson, Philip C. http://orcid.org/0000-0002-3156-3418
van der Linden, Sjef http://orcid.org/0000-0002-0087-0351
Khan, Muhammad A. http://orcid.org/0000-0003-4704-8311
Taylor, William J.
Article History
Accepted: 23 November 2020
First Online: 23 December 2020
Competing interests
: P.C.R. and W.J.T. are not members of ASAS and are not involved in the design or conduct of the CLASSIC study. P.C.R. declares that he has received research grants from Janssen, Novartis, Pfizer and UCB and has received speakers’ fees and/or acted as a consultant for AbbVie, Lilly, Gilead, Janssen, Novartis, Pfizer, Roche and UCB and received support to attend a meeting from BMS. M.A.K. is a member of ASAS and was involved in the design but not in the conduct of the CLASSIC study. M.A.K. declares that he has acted as a consultant for AbbVie, Lilly and Novartis, and has received speakers’ fees from AbbVie and Novartis. S.v.d.L. is a member of ASAS and is not involved in the design or conduct of the CLASSIC study.